跳至主要内容
临床试验/ACTRN12611001095954
ACTRN12611001095954招募中4 期

Treatment of chronic refractory urticaria with adalimumab

Senior doctor Claus Zachariae0 个研究点目标入组 10 人开始时间: 2011年10月21日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 67 Years(—)
性别
All

入选标准

  • Patients with chronic urticaria. Duration of chronic urticaria more than 6 months with maximum 2 days between urticaria outbreaks. Unsatisfactory treatment with high dose antihistamines, prednisolone and at least one other immunosuppressive drug for at least 3 months. Unsatisfactory treatment is defined as symptoms several times at week despite treatment.

排除标准

  • Pregnancy and lactation
  • Diabetes Mellitus
  • Severe heart disease, kidney disease or liver disease
  • Chronic infections
  • Former malignancies except non-melanoma skin cancer
  • Former treatment with tumour necrosis factor alpha-inhibitors

研究者

发起方
Senior doctor Claus Zachariae

相似试验